Clover Health Investments (CLOV) Revenue (2020 - 2026)

Clover Health Investments' Revenue history runs 7 years deep, the most recent figure standing at $744.2 million for Q1 2026.

• Quarterly Revenue rose 60.96% year-over-year to $744.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 48.31% YoY) and the FY2025 annual result came in at $1.9 billion, up 40.66% from the prior year.
• Revenue was $744.2 million for Q1 2026 at Clover Health Investments, up from $455.1 million in the prior quarter.
• Across five years, Revenue topped out at $744.2 million in Q1 2026 and bottomed at $267.9 million in Q3 2022.
• A 5-year average of $369.7 million and a median of $317.1 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue sank 34.73% — and 2026, when it surged 60.96%.
• Clover Health Investments' Revenue stood at $282.0 million in 2022, then increased by 1.99% to $287.6 million in 2023, then rose by 8.03% to $310.7 million in 2024, then jumped by 46.48% to $455.1 million in 2025, then surged by 63.51% to $744.2 million in 2026.
• Business Quant data shows CLOV's Revenue at $744.2 million in Q1 2026, $455.1 million in Q4 2025, and $496.6 million in Q3 2025.